TAPENTO IR 50MG TABLET
Tapento Ir 50mg Tablet ₨ 300
Back to products
HIBAS FACE WASH LEMON
Hibas Face Wash Lemon ₨ 380
EMPA L 25/5 TABLET
Weather Folds Pharmaceuticals

Empa L 25/5 Tablet

₨ 1,260

In stock
Pack size28
FormTablet
12+ other brands with the same formulaCompare
Compare
Add to wishlist
Delivery in 2 to 3 working daysTo cities across Pakistan, delivery from ₨ 300
Cash on deliveryOr pay by bank transfer or card at checkout
Genuine productsFrom a DRAP-licensed pharmacy
Damaged or wrong item?We take it back. Read the return policy
Have a prescription? Upload it and our pharmacist will check your order.Questions about this product? WhatsApp 0336 3300001

About this product

Overview

EMPA L 25/5 TABLET is a pharmaceutical product that combines two active ingredients: Empagliflozin and Linagliptin. Each tablet contains 25mg of Empagliflozin and 5mg of Linagliptin. Empagliflozin belongs to a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. This combination medication is used to manage blood sugar levels in individuals with type 2 diabetes mellitus.

Uses

EMPA L 25/5 TABLET is primarily used for the following purposes:

  1. Type 2 Diabetes: It is used to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin works by inhibiting the reabsorption of glucose by the kidneys, leading to increased urinary glucose excretion. Linagliptin, on the other hand, works by inhibiting the enzyme DPP-4, which helps regulate blood sugar levels.

Side Effects

EMPA L 25/5 TABLET is generally well-tolerated. However, like other medications, it may cause certain side effects in some individuals. Common side effects may include:

  1. Genital Infections: SGLT2 inhibitors like Empagliflozin may increase the risk of genital infections, such as urinary tract infections and yeast infections.
  2. Hypoglycemia: When used in combination with other antidiabetic medications such as insulin or sulfonylureas, EMPA L tablet may increase the risk of hypoglycemia (low blood sugar). This is more likely to occur if the dosage of the other antidiabetic medications is not adjusted appropriately.
  3. Increased Urination and Thirst: The action of Empagliflozin in increasing urinary glucose excretion may lead to increased urination and thirst.
  4. Gastrointestinal Effects: Nausea, diarrhea, and abdominal discomfort may occur in some cases.
  5. Allergic Reactions: Allergic reactions to either Empagliflozin or Linagliptin, although rare, can occur and may manifest as skin rash, itching, swelling, or other signs of an allergic response.

If any unexpected or severe side effects occur while using EMPA L 25/5 TABLET, it is advisable to discontinue its use and consult a healthcare professional.

When Not to Use

EMPA L 25/5 TABLET should not be used under certain conditions or circumstances, including:

  1. Type 1 Diabetes: It is not indicated for the treatment of type 1 diabetes.
  2. Allergy: If you have a known allergy or hypersensitivity to Empagliflozin, Linagliptin, or any other ingredients present in the tablet, it is recommended to avoid its use.
  3. Diabetic Ketoacidosis: EMPA L tablet is contraindicated in individuals with diabetic ketoacidosis, a serious complication of diabetes.
  4. Severe Renal Impairment: It should be used with caution or avoided in individuals with severe renal impairment or end-stage renal disease.
  5. Pregnancy and Breastfeeding: It is important to consult with a healthcare professional before using EMPA L 25/5 TABLET during pregnancy or while breastfeeding to assess the potential risks and benefits.

It is essential to follow the prescribed dosage and consult with a healthcare professional if you have any concerns or specific medical conditions before using EMPA L 25/5 TABLET. Regular monitoring of blood sugar levels and periodic evaluation by a healthcare professional is recommended during the use of this medication.

Health guide

Glucose meter and test strips for diabetesDiabetes Medicines Explained: Metformin, Gliclazide, SGLT2 Tablets and InsulinHow the main groups of diabetes medicines work, their key side effects, how to treat low sugar, sick-day...Read the guide →

This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.

Other brands of EMPAGLIFLOZIN + Linagliptin

These medicines also contain EMPAGLIFLOZIN + Linagliptin, but in a different strength or pack. Do not switch to a different strength without asking your doctor.

MedicineManufacturerStrengthPrice
Glem Lin 10/5mg TabletNabiqasim Industries10/5mgRs 360
Linvesta Emp 10mg/5mg TabletWilshire Laboratories10mg/5mgRs 377
Empaa L 25/5 mg TabletWeather Fold Pharmaceuticals25/5mgRs 429.94
Emsyn Lee 5/10mg TabletSearle Company5/10mgRs 453
Empagen L 5/10mg TabletFerozsons Laboratories5/10mgRs 454
Xenglu Lin 10/5mg TabletHilton Pharma10/5mgRs 520
Linvesta Emp 25/5mg TabletWilshire Laboratories25/5mgRs 558
Linvesta Emp 25mg/5mg TabletWilshire Laboratories25mg/5mgRs 558

Customer reviews

0 reviews
0
0
0
0
0

Reviews

Clear filters

There are no reviews yet.

Be the first to review “Empa L 25/5 Tablet”